Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,768 | $78.44 | $530,881.92 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 379,534 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 6,768 shares sold at prices ranging from $78.31 to $78.80 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 9,869 | $77.97 | $769,485.93 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 386,302 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 9,869 shares sold at prices ranging from $77.29 to $78.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,872 | $76.35 | $142,927.20 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 396,171 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 1,872 shares sold at prices ranging from $76.00 to $76.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 241 | $75.25 | $18,135.25 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,043 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 241 shares sold at prices ranging from $74.86 to $75.83 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-25-004076 · wk-form4_1738791860.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 41,140 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · derivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,140 shares Expires 2027-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $16.16 | $0.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · derivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 91,140 | $80.00 | $7,291,200.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,083 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionCommon Stock | 41,140 | $13.67 | $562,383.80 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 21:33 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionCommon Stock | 50,000 | $16.16 | $808,000.00 |
DisclosureSEC source: 0001628280-25-003322 · wk-form4_1738359228.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,830 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · derivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 218,630 Underlying: Common Stock · 6,830 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · derivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 18,750 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 631 | $71.01 | $44,807.31 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 233,924 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 631 shares sold at prices ranging from $70.92 to $71.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 4,700 | $70.31 | $330,457.00 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 234,555 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 4,700 shares sold at prices ranging from $69.91 to $70.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 1,499 | $69.40 | $104,030.60 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 239,255 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 1,499 shares sold at prices ranging from $68.87 to $69.87 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,830 | $10.85 | $74,105.50 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Indirect · By the Katie Procter Dynasty Trust Disclosed balance after: 240,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,473 | $71.05 | $175,706.65 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 379,534 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 2,473 shares sold at prices ranging from $70.89 to $71.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 22,696 | $70.32 | $1,595,982.72 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 382,007 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 22,696 shares sold at prices ranging from $69.89 to $70.89 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,636 | $69.39 | $460,472.04 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 404,703 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 6,636 shares sold at prices ranging from $68.87 to $69.86 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:37 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 18,750 | $22.76 | $426,750.00 |
DisclosureSEC source: 0001628280-25-001732 · wk-form4_1737063445.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 411,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:38 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 1,384 | $68.72 | $95,108.48 |
DisclosureSEC source: 0001628280-25-001736 · wk-form4_1737063475.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,165 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:37 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 1,457 | $68.72 | $100,125.04 |
DisclosureSEC source: 0001628280-25-001735 · wk-form4_1737063465.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,082 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:37 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 872 | $68.72 | $59,923.84 |
DisclosureSEC source: 0001628280-25-001733 · wk-form4_1737063455.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,083 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 4,801 | $63.62 | $305,439.62 |
DisclosureSEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · nonDerivative · entry 5 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,549 F6 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 1,371 | $63.73 | $87,373.83 |
DisclosureSEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · nonDerivative · entry 4 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,350 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 1,066 | $63.72 | $67,925.52 |
DisclosureSEC source: 0001628280-25-001206 · wk-form4_1736552720.xml · nonDerivative · entry 4 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,863 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 3,092 | $63.62 | $196,713.04 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,955 F6 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 965 | $63.87 | $61,634.55 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,047 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 287 | $65.40 | $18,769.80 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 6 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,562 F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 2,978 | $63.36 | $188,686.08 |
DisclosureSEC source: 0001628280-25-001203 · wk-form4_1736552690.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,589 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:44 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 319 | $63.38 | $20,218.22 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,965 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:44 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 3,604 | $63.62 | $229,286.48 |
DisclosureSEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 5 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,539 F6 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:44 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 1,298 | $63.86 | $82,890.28 |
DisclosureSEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 4 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,143 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 31,930 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · derivative · entry 6 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,930 Underlying: Common Stock · 31,930 shares Expires 2035-01-08 F7 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 6,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · nonDerivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,721 F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 1,702 | $66.16 | $112,604.32 |
DisclosureSEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,064 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Bonstein SaraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 31,930 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001206 · wk-form4_1736552720.xml · derivative · entry 5 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,930 Underlying: Common Stock · 31,930 shares Expires 2035-01-08 F6 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 6,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001206 · wk-form4_1736552720.xml · nonDerivative · entry 3 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,929 F4 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 1,464 | $66.05 | $96,697.20 |
DisclosureSEC source: 0001628280-25-001206 · wk-form4_1736552720.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,272 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 27,370 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · derivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,370 Underlying: Common Stock · 27,370 shares Expires 2035-01-08 F7 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 5,706 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,012 F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 1,209 | $65.84 | $79,600.56 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,306 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 31,930 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · derivative · entry 8 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,930 Underlying: Common Stock · 31,930 shares Expires 2035-01-08 F8 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
GrantCommon Stock | 6,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 5 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,849 F5 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F6 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 392 | $66.21 | $25,954.32 |
DisclosureSEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 4 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,192 F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantStock Option (right to buy) · Derivative | 109,490 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001203 · wk-form4_1736552690.xml · derivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,490 Underlying: Common Stock · 109,490 shares Expires 2035-01-08 F5 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantCommon Stock | 22,824 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001203 · wk-form4_1736552690.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,567 F3 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F4 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 3,999 | $65.96 | $263,774.04 |
DisclosureSEC source: 0001628280-25-001203 · wk-form4_1736552690.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,743 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC |
Smith Michael AlexanderChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 27,370 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · derivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,370 Underlying: Common Stock · 27,370 shares Expires 2035-01-08 F6 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.